CORCEPT THERAPEUTICS INC Operating Expenses
CORCEPT THERAPEUTICS INC (CORT) reported Operating Expenses of $13.16 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2015-11-06
- CORCEPT THERAPEUTICS INC operating expenses for the quarter ending 2015-09-30 was $13.16M, a 6.25% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating expenses for the quarter ending 2015-06-30 was $13.12M, a 5.55% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating expenses for the quarter ending 2015-03-31 was $14.13M, a 18.14% decline year-over-year.
- CORCEPT THERAPEUTICS INC operating expenses for the quarter ending 2014-12-31 was $12.09M, a 14.52% decline year-over-year.
- CORCEPT THERAPEUTICS INC operating expenses for fiscal 2014 was $54.17M, a 4.47% increase from fiscal 2013.
- CORCEPT THERAPEUTICS INC operating expenses for fiscal 2013 was $51.85M, a 31.01% increase from fiscal 2012.
- CORCEPT THERAPEUTICS INC operating expenses for fiscal 2012 was $39.58M, a 22.41% increase from fiscal 2011.
- CORCEPT THERAPEUTICS INC operating expenses for fiscal 2011 was $32.33M, a 17.84% increase from fiscal 2010.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 158 month | Operating Expenses 161 month | Operating Expenses 164 month | Operating Expenses 167 month |
|---|---|---|---|---|---|---|---|---|
| 2015-09-30 | $13.16M 10-Q · filed 2015-11-06 | $26.28M derived: sum of 2 quarters · filed 2015-11-06 | $40.41M 10-Q · filed 2015-11-06 | $52.50M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2015-06-30 | $13.12M 10-Q · filed 2015-08-07 | $27.25M 10-Q · filed 2015-08-07 | $39.34M derived: sum of 3 quarters · filed 2015-08-07 | $51.73M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2015-03-31 | $14.13M 10-Q · filed 2015-05-08 | $26.22M derived: sum of 2 quarters · filed 2015-05-08 | $38.61M derived: sum of 3 quarters · filed 2015-11-06 | $51.04M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-12-31 | $12.09M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $24.48M derived: sum of 2 quarters · filed 2015-11-06 | $36.91M derived: sum of 3 quarters · filed 2015-11-06 | $54.17M 10-K · filed 2015-03-13 | ||||
| 2014-09-30 | $12.38M 10-Q · filed 2015-11-06 | $24.82M derived: sum of 2 quarters · filed 2015-11-06 | $42.08M 10-Q · filed 2015-11-06 | $56.23M derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | $12.43M 10-Q · filed 2015-08-07 | $29.70M 10-Q · filed 2015-08-07 | $43.84M derived: sum of 3 quarters · filed 2015-08-07 | $56.22M derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | $17.26M 10-Q · filed 2015-05-08 | $31.41M derived: sum of 2 quarters · filed 2015-05-08 | $43.78M derived: sum of 3 quarters · filed 2015-05-08 | $56.46M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $14.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $26.52M derived: sum of 2 quarters · filed 2015-03-13 | $39.19M derived: sum of 3 quarters · filed 2015-03-13 | $51.85M 10-K · filed 2015-03-13 | ||||
| 2013-09-30 | $12.37M 10-Q · filed 2014-11-07 | $25.05M derived: sum of 2 quarters · filed 2014-11-07 | $37.71M 10-Q · filed 2014-11-07 | $49.06M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $12.67M 10-Q · filed 2014-08-08 | $25.34M 10-Q · filed 2014-08-08 | $36.69M derived: sum of 3 quarters · filed 2015-03-13 | $45.42M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $12.66M 10-Q · filed 2014-05-12 | $24.02M derived: sum of 2 quarters · filed 2015-03-13 | $32.74M derived: sum of 3 quarters · filed 2015-03-13 | $41.21M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $20.08M derived: sum of 2 quarters · filed 2015-03-13 | $28.55M derived: sum of 3 quarters · filed 2015-03-13 | $39.58M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $8.73M 10-Q · filed 2013-11-12 | $17.19M derived: sum of 2 quarters · filed 2013-11-12 | $28.22M 10-Q · filed 2013-11-12 | $38.15M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $8.47M 10-Q · filed 2013-08-09 | $19.50M 10-Q · filed 2013-08-09 | $29.42M derived: sum of 3 quarters · filed 2014-03-14 | $35.86M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $11.03M 10-Q · filed 2013-05-08 | $20.96M derived: sum of 2 quarters · filed 2014-03-14 | $27.39M derived: sum of 3 quarters · filed 2014-03-14 | $36.26M derived: sum of 4 quarters · filed 2014-03-14 | $225.77M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $16.36M derived: sum of 2 quarters · filed 2014-03-14 | $25.23M derived: sum of 3 quarters · filed 2014-03-14 | $32.33M 10-K · filed 2014-03-14 | $214.74M 10-K · filed 2012-03-13 | |||
| 2011-09-30 | $6.44M 10-Q · filed 2012-11-08 | $15.31M derived: sum of 2 quarters · filed 2012-11-08 | $22.40M 10-Q · filed 2012-11-08 | $30.23M derived: sum of 4 quarters · filed 2013-03-15 | $204.81M 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $8.87M 10-Q · filed 2012-08-09 | $15.97M 10-Q · filed 2012-08-09 | $23.79M derived: sum of 3 quarters · filed 2013-03-15 | $30.90M derived: sum of 4 quarters · filed 2013-03-15 | $198.38M 10-Q · filed 2011-08-09 | |||
| 2011-03-31 | $7.10M 10-Q · filed 2012-05-10 | $14.92M derived: sum of 2 quarters · filed 2013-03-15 | $22.03M derived: sum of 3 quarters · filed 2013-03-15 | $28.47M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2010-12-31 | $7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $14.93M derived: sum of 2 quarters · filed 2013-03-15 | $21.37M derived: sum of 3 quarters · filed 2013-03-15 | $27.44M 10-K · filed 2013-03-15 | ||||
| 2010-09-30 | $7.11M 10-Q · filed 2011-11-08 | $13.55M derived: sum of 2 quarters · filed 2011-11-08 | $19.61M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $6.45M 10-Q · filed 2011-08-09 | $12.51M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $20.28M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |